Cannabis

Tuesday Dec 27, 2022 - 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Increase Bioavailability in Pharmaceuticals

Studies have indicated that around 40% of the available drugs on the market offer poor bioavailability Lexaria’s patented DehydraTECH(TM) technology increases bioavailability, improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery The global pharmaceutical drug delivery market was valued at $1.66 billion in 2021 and is expected to grow at a CAGR of 5.9%, resulting in a value…

Thursday Dec 22, 2022 - 10:30 am

REZYFi, Inc. Continues to Diversify Lending and Mortgage Industry, as Mortgage Rates Show Decline for Fifth Week in a Row

REZYFi is targeting licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners who seek a variety of real estate-related first and additional mortgage-based financing and project-specific financing The sale of legal recreational marijuana in California in 2016 reached $2.69 billion and is expected to grow to $6.59 billion by 2025. Since passing laws for recreational…

Thursday Dec 22, 2022 - 9:00 am

Luis Merchan, Helping Flora Growth Corp. (NASDAQ: FLGC) Become Global Leader in the CBD Space

Luis Merchan was appointed President of Consumer Goods at Flora in July 2020 before being appointed as the company’s CEO five months later, and chairman of its Board of Directors in May 2022 Merchan would lend his years of experience at Macy’s, where he led various sales and marketing initiatives, including the B2B corporate team responsible for bringing in $160 million in annual revenue Under…

Tuesday Dec 20, 2022 - 11:15 am

Jupiter Wellness Inc. (NASDAQ: JUPW) Issues Letter to Shareholders with Update on Key Corporate Milestones, Product Progress

Jupiter Wellness has announced that the “FDA of India” has approved its topical treatment for psoriasis and vitiligo, with a market launch to follow The global vitiligo treatment market was valued at $1.2 billion in 2018 and is expected to grow at a CAGR of 5.8%, resulting in a value of approximately $2 billion by 2026 JW-500, a topical treatment for female sexual wellness, is…

Monday Dec 19, 2022 - 12:00 pm

Policymaker Optimism for Real Estate Lending Trends Portends Blue Sky Opportunity for Mortgage Loan Facilitator REZYFi, Inc.

Real estate market watchers have been encouraged by recent trends in inflationary policy and lending policy analysis The mid-December Consumer Price Index report and the subsequent Federal Reserve funds rate decision fell in line with expectations that inflation may have passed its peak and is beginning to decline Real estate lenders expect mortgage rates to trend lower as a result of the policy news Miami-based…

Thursday Dec 15, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing the Seizure Treatment Market with Successful EPIL-A21-1 Animal Study

Epilepsy affects one in every 26 people globally, with as many as one million ED visits, 280 hospital admissions, average hospital stays of 3.6 days, and an aggregate hospital cost of approximately $2.5 billion annually With its severity, prevalence, and overall cost implications, Lexaria is looking to offer an alternative option with its patented DehydraTECH(TM)-CBD Its recent animal seizure study, EPIL-A21-1, showed DehydraTECH-CBD to be…

Tuesday Dec 13, 2022 - 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 2022 Calendar Year in Review

Lexaria Bioscience is a global innovator in drug delivery platforms whose patented DehydraTECH(TM) technology has demonstrated the ability to improve the bioavailability and increase the speed of onset of many drugs In calendar 2022, the company achieved a number of milestones in various areas, including research programs, receipt of patents, and licensing agreements Lexaria started and completed its fourth and most comprehensive hypertension study yet,…

Monday Dec 12, 2022 - 12:00 pm

REZYFi, Inc. to Benefit as Marijuana Sales Projected to Hit $53 Billion by 2026

Marijuana sales are projected to hit $33 billion in 2022, up from $3 billion in 2015, and are on track to hit $53 billion by 2026 REZYFi, a growth mortgage origination and specialized financing company, with target markets including the legalized cannabis industry, is set to be one of the key beneficiaries in this anticipated growth With the ongoing conversation around marijuana, along with the…

Thursday Dec 08, 2022 - 9:45 am

Improving Loan Origination Landscape is Positive News for Mortgage Loan Clients, Mortgage Loan Facilitator REZYFi, Inc.

Miami-based REZYFi is a mortgage lender working with traditional loans but focusing particular attention on unbanked market sectors such as the cannabis industry and those property companies that provide leases to those sectors The loan origination industry appears to be experiencing a new round of greening in reversal of the year’s difficulties In the wake of positive CPI data last month, analysts are beginning to…

Wednesday Dec 07, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Findings of Animal Anti-Seizure Study Program Suggesting that DehydraTECH(TM)-CBD Is More Effective at Lower Doses and Works More Rapidly than FDA-Approved Epidiolex

Lexaria recently announced the findings of the first two studies from its EPIL-A21-1 animal research program The program is designed to assess the effectiveness of patented DehydraTECH(TM)-CBD in reducing or eliminating seizure activity compared to Epidiolex, a CBD-based anti-seizure drug The first study evidenced that DehydraTECH-CBD is more efficacious at lower doses than Epidiolex The second study demonstrated DehydraTECH-CBD’s enhanced effectiveness; specifically, the formulation acted…

Monday Dec 05, 2022 - 11:15 am

REZYFi, Inc. Eyes Developing Californian Cannabis Market Amid Approval of Ballot Measures to Expand Retail

California voters recently approved 12 local ballot measures in the 2022 midterm elections to either expand or create cannabis markets in a dozen municipalities These approvals, it is projected, will translate to over 70 new retail licenses and countless other business opportunities for plant-touching and ancillary companies that serve those retailers Having positioned itself as one of the first cannabis mortgage bankers in the United…

Friday Dec 02, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves Forward With Exploration of Patented DehydraTECH(TM)-Processed CBD for Dementia

Approximately 55 million people worldwide have dementia, which is expected to grow to 78 million by 2030 The dementia treatment market was valued at $13.78 billion in 2021. The market is expected to grow at a CAGR of 8.32%, resulting in a value of $26.13 billion by 2029 Clinical studies have established a connection between hypertension and dementia With DehydraTECH(TM)-CBD already evidencing that it can…

Wednesday Nov 30, 2022 - 12:00 pm

REZYFi, Inc.’s Financing Services Filling Funding Gap for Cannabis Entrepreneurs, Real Estate Owners

REZYFi is a growth mortgage origination and specialized financing company in the U.S. that primarily serves licensed and permitted cannabis companies and owners of real estate who lease to cannabis companies Entrepreneurs have for a long time faced barriers to starting cannabis businesses, including lack of access to capital, a two-tiered regulatory system, and an uneven playing field Some cities in states where medical and…

Tuesday Nov 29, 2022 - 1:30 pm

Prime Harvest Inc. Positioned to Lead California’s Cannabis Market with Direct-to-Consumer Expansion

Prime Harvest is the parent company of Jaxx Cannabis, its D2C operations actively expanding throughout California Prime Harvest’s brand partners strongly positioned across multiple segments of the cannabis value chain Brand partners include Mary's Medicinals, STIIIZY, Lime Cannabis, and Tonik Revenue diversification is critical to sustainable growth in the cannabis industry, and it’s central to the strategy of Prime Harvest, a technology-focused, full-service cannabis corporation.…

Tuesday Nov 29, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Investigation of DehydraTECH-CBD’s Potential Therapeutic Value for Diabetes and Defmentia with New Studies

Lexaria’s Patented DehydraTECH technology improves the bioavailability of pharmaceuticals and therapeutics for a number of developing applications Lexaria is set to complete its DEM-A22-1 and DIAB-A22-1 studies on dementia and diabetes, respectively, in January 2023, with analysis and reporting set to follow soon after These studies will build on the just-concluded hypertension clinical study whose results were “truly exceptional,” demonstrating a statistically significant lowering of…

Monday Nov 28, 2022 - 12:00 pm

Lift Events & Experiences to Bring Unique Cannabis Conference, Trade Show and Associated Opportunities to the U.S. Cannabis Market

Become a part of the 2023 U.S. debut of Lift Events & Experiences, at the Moscone Center in San Francisco, from Wednesday, August 2 – Friday, August 4, 2023. The leader in Canada, Lift’s first conference over the border offers exclusive content, robust networking, and unparalleled new product discovery opportunities. The event is dedicated to the evolution of the cannabis industry, and brings to the…

Monday Nov 28, 2022 - 10:30 am

REZYFi, Inc. Leverages Growth of California’s Cannabis Market as It Expands to Include Social Equity Provisions, More Opportunities for Business Owners

California retail stores sold almost $5.3 billion worth of cannabis products in 2021 and reported a total tax revenue of approximately $1.3 billion California’s three licensing authorities issued 12,227 commercial cannabis licenses to businesses throughout the state during 2021 San Diego has approved a social-equity program, joining the ranks of other California cities and counties that have implemented them since 2018, utilizing tax revenues from…

Wednesday Nov 23, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches Animal Study to Evaluate Potential Therapeutic Effect of DehydraTECH-CBD on Dementia

Lexaria Bioscience has launched DEM-A22-1, its first-ever study to investigate whether its patented DehydraTECH(TM)-processed CBD may have therapeutic use against dementiaThe animal study will involve a total of 32 Long Evans rats and will involve a memory assessment test that will be utilized to investigate whether CBD enables cognitive performance enhancementsPrevious independent studies have shown that CBD prevents the development of a social recognition deficit,…

Tuesday Nov 22, 2022 - 12:45 pm

REZYFi, Inc. Continues to See Opportunity in Serving Cannabis-Related Companies Amid Marijuana Rescheduling Efforts in the US

REZYFi is a Miami, Florida-headquartered growth mortgage origination and specialized financing company that primarily targets licensed and permitted cannabis companies and owners of real estate who lease to cannabis companiesTraditional banks are governed by federal law, which criminalizes marijuana; as a result, they are hesitant to offer financial services to cannabis businessesThe President recently set a process in motion that could culminate in the rescheduling…

Monday Nov 21, 2022 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off First-Ever Study on DehydraTECH-CBD for the Potential Treatment of Diabetes

In November 2021, Lexaria laid out its plans for several new and ongoing R&D programs, among them hormone replacement, dementia, rheumatoid disease, and diabetesThe company has since begun its DIAB-A22-1 study program on the effectiveness of the patented DehydraTECH(TM)-processed CBD for the potential therapeutic utility against diabetesLexaria is optimistic that the study will yield some notable results, particularly with DehydraTECH-CBD having met primary safety and…

Thursday Nov 17, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Approved to Proceed with Human Study Evaluating Effectiveness of Patented DehydraTECH(TM) Technology in Boosting Oral-Tissue Absorption of Nicotine

Lexaria Bioscience recently received Independent Review Board approval for its upcoming human clinical nicotine study, NIC-H22-1, and expects to begin dosing soonThe company hopes to evidence that processing purified nicotine with its patented DehydraTECH(TM) drug delivery technology leads to better oral-tissue absorption and reduced negative experiences compared to leading brands currently available on the market, On! and ZynLast year, Lexaria conducted an animal study evaluating…

Friday Nov 11, 2022 - 9:00 am

Zacks SCR Uses Lexaria Bioscience Corp. (NASDAQ: LEXX) HYPER-H21-4 Study to Support $15 Share Valuation

Lexaria’s HYPER-H21-4 human clinical study was a success, producing favorable results in treating hypertension when comparing the company’s patented DehydraTECH(TM) CBD with a placeboAccording to a Zacks SCR report, the findings support their $15 share valuation of the companyZacks expects Lexaria to penetrate global markets for hypertension, nicotine delivery and antiviral productsThe hypertension drug market is expected to grow to over $34 billion through 2030,…

Thursday Nov 10, 2022 - 11:15 am

Specialized Market Lender REZYFi, Inc. Believes They Have Real Opportunity Amid Challenges Faced by Traditional Lenders

While economies worldwide are struggling to control spiking inflation rates, REZYFi, a mortgage lender servicing non-traditional as well as other loans, sees unique financial opportunitiesThrough the use of proprietary automated machine learning and associated technologies, together with preparations to launch a high-margin cannabis division later this year to serve an industry in need of loan origination options, REZYFi is working to grow its operationRZFI is…

Wednesday Nov 09, 2022 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Defines Path to Profitability and Portfolio Expansion with Proposed Franchise Global Health Inc. Acquisition

Flora Growth signed a definitive agreement with FGH to acquire 100% of all issued and outstanding shares by way of a statutory plan of agreementThe deal is expected to close in December following the presentation of the agreement to shareholders; the acquisition will open Flora to the German and EU medical markets, increasing the company’s international revenue and providing essential distribution to German pharmacies and…

Tuesday Nov 08, 2022 - 11:15 am

REZYFi, Inc. Leverages Cannabis Industry Interests to Diversify Banking and Real Estate as DCC Prioritizes Research Project Funding

The California Department of Cannabis Control (“DCC”) has reserved $20 million in funding for research prioritizing cannabis projects, including potency, health impact, medicinal use, legacy cannabis genetics, and industry healthThe medicinal and recreational cannabis market size in the US is anticipated to reach $33 billion in 2022, with a revenue outlook of $52.6 billion by 2026REZYFi Inc., through two wholly-owned subsidiaries, is positioned to be…

Tuesday Nov 08, 2022 - 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Aiming to Address Unmet Patient Needs of Hypertensive Patients

Lexaria just completed its HYPER-H21-4 human clinical hypertension study, posting a sustained drop in blood pressure in normally active hypertensive patientsWith the success of this study, the company is working towards an IND application to seek FDA approval for its patented DehydraTECH(TM)-enabled CBD capsule formulation. 47% of adults live with hypertension but only 24% of them have it under controlWith its DehydraTECH-CBD, Lexaria hopes to not…

Monday Nov 07, 2022 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Agreement to Acquire Multi-national Cannabis Operator Positions Company for New Strategic Growth in Europe

Flora Growth is a cannabis cultivator and international brand developer with a strong base of operations at its licensed facility in northern ColombiaFlora recently announced its plans to acquire multi-national operator Franchise Global Health (“FGH”), the latest of its strategic acquisitions designed to boost revenues and expand Flora’s international footprintFGH is focused on the German market, where its subsidiary was the first company to sell…

Friday Nov 04, 2022 - 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Zero Adverse Effects from Successful HYPER-H21-4 Study of DehydraTECH(TM)-CBD for High Blood Pressure

The CDC reported more than 670,000 annual deaths in the United States with high blood pressure as a primary or contributing causeLexaria's patented DehydraTECH(TM) technology has been shown, through HYPER-H21-4 study, to decrease high blood pressure in subjects through DehydraTECH-CBD-enabled dosingThe global antihypertension drug market was valued at over $22.5 billion in revenue in 2018 and is expected to grow at a CAGR of 3.1%,…

Thursday Nov 03, 2022 - 10:30 am

Tampa Alternative Products Expo Brings Together The Local Community For Three Days of Festivity And Business Networking

After various successful shows across North and South America, Alternative Products Expo is coming to Tampa, Florida, this November 10-10, at Tampa's Convention Center. The event has something for everyone. It features over 250 industry vendors, 20+ speakers from across the industry, and many contests and giveaways. Starting some years ago with a series of successful Vape events, the Alt Pro Expo team ventured into…

Thursday Nov 03, 2022 - 9:00 am

Cannabis Regulation in the Spotlight During Midterm Elections at the Heels of Presidential Pardon; Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombian Stance to Manufacture Products at Lower Costs

President Biden issued a pardon for federally incarcerated inmates with minor marijuana possession charges, urging governors to do the same at the state levelThe President also requested a reclassification of cannabis, as it is currently listed above other drugs which are key factors in the overdose epidemicFlora Growth, through its Colombian cultivation, is producing a higher quality product at lower-than-average cost margins due to the…

Wednesday Nov 02, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Maintains Late 2022/Early 2023 for Full IND Application for DehydraTECH-CBD

Lexaria, through its patented DehydraTECH(TM) technology, is improving the bioavailability of pharmaceuticals and therapeutics (in part) by bypassing first-pass-liver processing, thereby achieving an improved speed of onset, and brain absorption of APIsHypertension currently affects nearly 50% of all American adults, with the American Heart Association describing it as a “silent killer”, and is now being studied for its effects during pregnancyThe company has received positive…

Tuesday Nov 01, 2022 - 12:00 pm

Tampa Alternative Products Expo To Offer A Festive Vibe Amongst Business Networking

Exhibitors, speakers, businesses, CBD and alternative products vendors, and researchers, are all invited to attend the Tampa Alternative Products Expo 2022 at the Tampa Convention Center. With over 10,000 attendees, 300+ vendors, and 20+ speakers per event, the Expo will exude a festival-like vibe for Tampa's CBD, cannabis, and vape communities. The event is organized by ZJ Events, with a reputation for managing the nation's…

Tuesday Nov 01, 2022 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Focusing on Execution and Brand Integration Following Successful Period of Strategic Investment

Flora Growth recently participated in an earnings call in which the management team discussed the company’s financials as well as its growth strategy and outlook for the remainder of fiscal 2022 as well as 2023The company noted it had exited a period of investment and is now focusing on executionThe period of investment saw the company acquire synergistic brands that, collectively, create a direct-to-consumer house…

Monday Oct 31, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves to Address Adverse Effects of Hypertension with DehydraTECH(TM) – CBD

Lexaria is a drug delivery technology company developing DehydraTECH-CBD as a prospective registered treatment for hypertension and potentially other disease states beyond hypertensionThe company has undertaken multiple de-risking hypertension studies that have not only evidenced that DehydraTECH-CBD is safe and well tolerated, but have also shown that it reduces blood pressure and arterial stiffnessHypertension is a leading contributor to deaths in the United States, damaging…

Wednesday Oct 26, 2022 - 9:00 am

Advanced Container Technologies Inc. (ACTX) Offers Growing Solution in Industry Seeing Key Government Support

California governor signs 10 cannabis-related bills into lawBills intended to “strengthen California’s cannabis laws, expand the legal cannabis market and redress the harms of cannabis prohibition”ACTX’s Grow Pods offer unmatched control, are capturing a great deal of attention in the cannabis and hemp space As California Gavin Newsom signed 10 cannabis-related legislative bills into law — all in one day (https://ibn.fm/ge2Kv) — companies operating in the…

Tuesday Oct 25, 2022 - 11:15 am

Lift&Co. Expo Vancouver 2023 to Introduce New Elements and Recognize Hidden Talents in the Cannabis Community

Join leading cannabis investors, processors, manufacturers, growers, brands, budtenders, retailers, educators, advocates, regulators and more at the Lift&Co. Vancouver Expo, 2023, being held from January 12-14, 2023, at the Vancouver Convention Centre. As Canada’s number-one cannabis conference and trade show, the event will bring unique and innovative ideas and elements as part of an immersive experience that keeps the audience engaged over the course of…

Tuesday Oct 25, 2022 - 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Potential Hypertension Medication Poised to Reduce Risk of Blood-Pressure-Induced Dementia, Cognitive Decline

Lexaria Bioscience is a global innovator in drug delivery platforms that has developed the patented DehydraTECH(TM) technology for improved delivery of bioactive compoundsThe company is currently evaluating DehydraTECH-processed CBD as a potential treatment for high blood pressureLong-term studies have shown that high blood pressure can increase the risk of developing dementia in later lifeExperts, however, believe that hypertension medication could slow the pace of the…

Monday Oct 24, 2022 - 9:00 am

Advanced Container Technologies Inc. (ACTX) Leaders Talk Game-Changing Microfarm Growing Option on Episode of Leading Podcast

ACTX CEO Doug Heldoorn, Grow Pod inventor Shannon Illingworth discuss the innovative microfarm option on recent Gamechangers LIVE podcastDiscussion focuses on history of company, significant health and safety benefits of Grow PodsCompany is dedicated to developing, manufacturing and selling advanced cultivation equipment and packaging systems Advanced Container Technologies (OTC: ACTX) chair and CEO Doug Heldoorn was a featured guest on a recent episode of the…

Wednesday Oct 19, 2022 - 12:00 pm

REZYFi, Inc. In Great Position as Efforts to Enrich Marijuana Jurisprudence Gain Steam

REZYFi is a mortgage origination and specialized financing company with a primary focus on providing senior loans and project financings to state-licensed operators in the cannabis industryThe company operates through two wholly owned subsidiaries, REZYFi Lending and ResMacREZYFi is in a position to benefit from recent efforts by the Biden administration and the U.S. Congress to reschedule and decriminalize marijuana, respectively, with the moves expected…

Wednesday Oct 19, 2022 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Building Portfolio of Brands that Resonates with End Consumers as It Targets Margins and Profitability

Flora Growth is a global cannabis company building a connected, design-led collective of plant-based wellness and lifestyle brandsThe company’s portfolio of brands is designed to deliver the most compelling customer experiences in the worldThrough its M&A strategy, Flora Growth has brought on board brands like JustCBD, Vessel Brands Inc., Masaya, No Cap Hemp Co., and MambeFlora hopes to establish meaningful connections with consumers through these…

Articles

Articles Category: Cannabis

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions